Morschhauser, F., Tilly, H., Chaidos, A., McKay, P., Phillips, T., Assouline, S., Batlevi, C. L., Campbell, P., Ribrag, V., Damaj, G. L., Dickinson, M., Jurczak, W., Kazmierczak, M., Opat, S., Radford, J., Schmitt, A., Yang, J., Whalen, J., Agarwal, S., Adib, D., & Salles, G. (2020). tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial. Lancet oncology, 21(11), 1433–1442. http://access.bl.uk/ark:/81055/vdc_100113642983.0x000014